The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 23121096 |
86 |
Ion channels as therapeutic targets: a drug discovery perspective. |
Pfizer |
| 18537233 |
108 |
Selective influence on contextual memory: physiochemical properties associated with selectivity of benzodiazepine ligands at GABAA receptors containing the alpha5 subunit. |
Moltech |
| 21277199 |
29 |
Exploring subtype selectivity and metabolic stability of a novel series of ligands for the benzodiazepine binding site of the GABAA receptor. |
Novartis Institutes For Biomedical Research |
| 15026049 |
42 |
Tricyclic pyridones as functionally selective human GABAA alpha 2/3 receptor-ion channel ligands. |
The Neuroscience Research Centre |
| 12408715 |
97 |
Synthesis and biological evaluation of 7,8,9,10-tetrahydroimidazo[1,2-c]pyrido[3,4-e]pyrimdin-5(6H)-ones as functionally selective ligands of the benzodiazepine receptor site on the GABA(A) receptor. |
Neurogen |
| 31738537 |
95 |
Subtype Selective ?-Aminobutyric Acid Type A Receptor (GABA |
University of Sussex |
| 26214255 |
11 |
The amylase inhibitor montbretin A reveals a new glycosidase inhibition motif. |
University of British Columbia |
| 25636004 |
12 |
Structure-guided design of a high affinity inhibitor to human CtBP. |
University of Massachusetts Medical School |
Search and Browse
